Lipocine Inc

NASDAQ:LPCN   3:59:44 PM EDT
1.30
-0.08 (-5.80%)
Products

Lipocine Says U.S. FDA HAS GRANTED TENTATIVE APPROVAL TO TLANDO

Published: 12/09/2020 01:59 GMT
Lipocine Inc (LPCN) - Lipocine Announces Tentative Approval of Tlando™.
U.S. Food and Drug Administration ("fda") Has Granted Tentative Approval to Tlando.
Tlando is Not Eligible for Final Approval and Marketing in U.S.